Literature DB >> 26584852

ESRRB polymorphisms are associated with comorbidity of temporomandibular disorders and rotator cuff disease.

L L Bonato1, V Quinelato1, A da R Pinheiro2, M V G Amaral3, F N de Souza1, J C Lobo4, D P Aguiar5, L M M Augusto5, A R Vieira6, J I Salles7, V R A Cossich7, J A M Guimarães8, C V D de Gouvêa9, J M Granjeiro10, P L Casado11.   

Abstract

Temporomandibular disorders (TMD) are associated with comorbidity. Shoulder pain is among the symptoms associated with TMD. The purpose of this study was to investigate the association between TMD and rotator cuff disease (RCD) and related genetic aspects. All subjects underwent orofacial and shoulder examinations. The control group comprised 30 subjects with no pain. Affected subjects were divided into three groups: RCD (TMD-free, n=16), TMD (RCD-free, n=13), and TMD/RCD (patients with both RCD and TMD, n=49). A total of eight single nucleotide polymorphisms in the ESRRB gene were investigated. A chemiluminescent immunoassay was used to measure estradiol levels. Surface electromyography recorded head and cervical muscle activity. The χ(2) test and Student t-test/Mann-Whitney test were used to assess the significance of nominal and continuous variables. A P-value of <0.05 was considered significant. TMD subjects were seven times more susceptible to RCD than controls. The rs1676303 TT (P=0.02) and rs6574293 GG (P=0.04) genotypes were associated with RCD and TMD, respectively. TMD/RCD subjects showed associations with rs4903399 (P=0.02), rs10132091 (P=0.02), and CTTCTTAG/CCTCTCAG (P=0.01) haplotypes and lower muscle activity. Estradiol levels were similar among groups. This study supports TMD as a risk factor for RCD. ESRRB haplotypes and low muscle activity are common biomechanical characteristics in subjects with both diseases.
Copyright © 2015 International Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  disease susceptibility; estradiol; polymorphism; rotator cuff disease; temporomandibular disorder

Mesh:

Substances:

Year:  2015        PMID: 26584852     DOI: 10.1016/j.ijom.2015.10.007

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Surg        ISSN: 0901-5027            Impact factor:   2.789


  6 in total

1.  CURRENT CONCEPTS ON THE GENETIC FACTORS IN ROTATOR CUFF PATHOLOGY AND FUTURE IMPLICATIONS FOR SPORTS PHYSICAL THERAPISTS.

Authors:  Travis Orth; Jessica Paré; John E Froehlich
Journal:  Int J Sports Phys Ther       Date:  2017-04

2.  Identification of a Novel Genetic Marker for Risk of Degenerative Rotator Cuff Disease Surgery in the UK Biobank.

Authors:  Elizabeth L Yanik; Jay D Keener; Shiow J Lin; Graham A Colditz; Rick W Wright; Bradley A Evanoff; Nitin B Jain; Nancy L Saccone
Journal:  J Bone Joint Surg Am       Date:  2021-07-21       Impact factor: 6.558

3.  Genome-wide association study identifies a locus associated with rotator cuff injury.

Authors:  Thomas R Roos; Andrew K Roos; Andrew L Avins; Marwa A Ahmed; John P Kleimeyer; Michael Fredericson; John P A Ioannidis; Jason L Dragoo; Stuart K Kim
Journal:  PLoS One       Date:  2017-12-11       Impact factor: 3.240

4.  The role of estrogen and progesterone receptors in the rotator cuff disease: a retrospective cohort study.

Authors:  Umile Giuseppe Longo; Alessandro Mazzola; Simone Carotti; Maria Francesconi; Simone Catapano; Francesco Magrì; Giuseppe Perrone; Sergio Morini; Sergio De Salvatore; Vincenzo Denaro
Journal:  BMC Musculoskelet Disord       Date:  2021-10-20       Impact factor: 2.362

Review 5.  Genetic overlap between temporomandibular disorders and primary headaches: A systematic review.

Authors:  Diogo Cruz; Francisca Monteiro; Maria Paço; Manuel Vaz-Silva; Carolina Lemos; Miguel Alves-Ferreira; Teresa Pinho
Journal:  Jpn Dent Sci Rev       Date:  2022-02-23

6.  Dental genetics in Brazil: Where we are.

Authors:  Priscila L Casado; Valquiria Quinelato; Patricia Cataldo; Juliana Prazeres; Mariana Campello; Leticia L Bonato; Telma Aguiar
Journal:  Mol Genet Genomic Med       Date:  2018-08-05       Impact factor: 2.183

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.